PS02.20 Subsequent Therapies Post-Afatinib Among Patients with EGFR Mutation-Positive (EGFRm+) NSCLC in LUX-Lung 3, 6 and 7: Topic: Medical Oncology

Journal of Thoracic Oncology(2017)

引用 5|浏览11
暂无评分
关键词
egfr,post-afatinib,mutation-positive,lux-lung
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要